AstraZeneca Expands AI Partnership with Immunai Through 2027 to Accelerate Oncology Drug Discovery
AstraZeneca has officially announced the expansion of its collaboration with Immunai, a New York-based AI biotechnology company, extending their partnership agreement through 2027. This strategic move underscores th...